FSH receptor polymorphisms and ovarian function

Medecine Therapeutique Medecine de la Reproduction, Gynecologie et Endocrinologie

Volumn 11, Issue 4, 2009, Pages 265-270

  Ochsenkühn, Robert ^a   Von Schönfeldt, Viktoria ^a   Simoni, Manuela ^b  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

Author keywords

FSH; Ovarian stimulation; Polymorphisms; Receptor; Reproduction

Indexed keywords

EID: 70349260255     PISSN: 1774640X     EISSN: None     Source Type: Journal    
DOI: 10.1684/mte.2009.0256     Document Type: Article

References (43)

1. Achrekar SK, Modi DN, Desai SK, Mangoli VS, Mahale SD. Poor ovarian response to gonadotropin stimulation is associated with FSH receptor polymorphism. Reprod Biomed Online 2009; 18: 509-515
2. Aittomaki K, Lucena JL, Pakarinen P, et al. Mutation in the follicle-stimulating hormone receptor gene causes hereditary hypergonadotropic ovarian failure. Cell 1995 ; 82 : 959-968
3. 3. Behre HM, Greb RR, Mempel A, et at. Significance of a common single nucleotide polymorphism in exon 10 of the folliclestimulating hormone (FSH) receptor gene for the ovarian response to FSH: a pharmacogenetic approach to controlled ovarian hyperstimulation. Pharmacogenet Genomics 2005 ; 15 : 451-456 (Pubitemid 41017593)
4. 4. Broekmans FJ, Kwee J, Hendriks DJ, Mol BW, Lambalk CB. A systematic review of tests predicting ovarian reserve and IVF outcome. Hum Reprod Update 2006; 12 : 685-718. (Pubitemid 44605509)
5. Broer SL, Mol BW, Hendriks D, Broekmans FJ. The role of antiMüllerian hormone in prediction of outcome after IVF: comparison with the antral follicle count. Fertil Steril 2009 ; 91 : 705-714
6. 6. Conway GS, Conway E, Walker C, Hoppner W, Gromoll J, Simoni M. Mutation screening and isoform prevalence of the follicle stimulating hormone receptor gene in women with premature ovarian failure, resistant ovary syndrome and polycystic ovary syndrome. Clin Endocrinol (Oxf) 1999 ; 51 : 97-99 (Pubitemid 29339541)
7. 7. Daelemans C, Smits G, de Maertelaer V, et al. Prediction of severity of symptoms in iatrogenic ovarian hyperstimulation syndrome by follicle-stimulating hormone receptor Ser680Asn polymorphism. J Clin Endocrinol Metab 2004 ; 89 : 6310-6315 (Pubitemid 39628451)
8. 8. de Castro F, Ruiz R, Montoro L, et al. Role of follicle-stimulating hormone receptor Ser680Asn polymorphism in the efficacy of follicle-stimulating hormone. Fertil Steril 2003 ; 80 : 571-576 (Pubitemid 37102868)
9. 9. de Castro F, Moron FJ, Montoro L, et al. Human controlled ovarian hyperstimulation outcome is a polygenic trait. Pharmacogenetics 2004; 14:285-293 (Pubitemid 38638915)
10. 10. de Koning CH, Benjamins T, Harms P, et al. The distribution of FSH receptor isoforms is related to basal FSH levels in subfertile women with normal menstrual cycles. Hum Reprod 2006; 21 : 443-446 (Pubitemid 43159920)
11. Devroey P, Fauser BCJM, Diedrich K. Approaches to improve the diagnosis and management of infertility. Hum Reprod Update 2009; 15:391-408.
12. 12. Dias JA, Cohen BD, Lindau-Shepard B, Nechamen CA, Peterson AJ, Schmidt A. Molecular, structural, and cellular biology of fol I ¡tropin and follitropin receptor. Vitam Horm 2002 ; 64 : 249-322. (Pubitemid 135763167)
13. 13. Falconer H, Andersson E, Aanesen A, Fried G. Folliclestimulating hormone receptor polymorphisms in a population of infertile women. Acta Obstet Gynecol Scand 2005 ; 84 : 806-811 (Pubitemid 41039907)
14. Fan QR, Hendrickson WA. Structure of human follicle stimulating hormone in complex with its receptor. Nature 2005 ; 433 : 269-277
15. Fauser BC, Van Heusden AM. Manipulation of human ovarian function: physiological concepts and clinical consequences. Endocr Rev 1997; 18:71-106.
16. 16. Georgiou I, Konstantelli M, Syrrou M, Messinis IE, Lolis DE. Oestrogen receptor gene polymorphisms and ovarian stimulation for in vitro fertilization. Hum Reprod 1997; 12 : 1430-1433 (Pubitemid 27373191)
17. 17. Greb RR, Grieshaber K, Gromoll J, et al. A common single nucleotide polymorphism in exon 10 of the human follicle stimulating hormone receptor is a major determinant of length and hormonal dynamics of the menstrual cycle. J Clin Endocrinol Metab 2005;90:4866-4872 (Pubitemid 41159384)
18. 18. Gromoll J, Simoni M. Genetic complexity of FSH receptor function. Trends Endocrinol Metab 2005 ; 16 : 368-373 (Pubitemid 41338742)
19. Gromoll J, Simoni M. Follicle-stimulating hormone receptor and twinning. Lancet 2001 ; 357 : 230.
20. 20. Hendriks DJ, Kwee J, Mol BW, te Velde ER, Broekmans FJ. Ultrasonography as a tool for the prediction of outcome in IVF patients: a comparative meta-analysis of ovarian volume and antral follicle count. Fertil Steril 2007 ; 87 : 764-775 (Pubitemid 46550395)
21. Heubner M, Riemann K, Otterbach F, et al. The haplotype of two FSHR polymorphisms in ovarian cancer - a potential role of ethnology in risk modification. Gynecol Oncol 2009 ; 112 : 486-489
22. Jun JK, Yoon JS, Ku SY, et al. Follicle-stimulating hormone receptor gene polymorphism and ovarian responses to controlled ovarian hyperstimulation for IVF-ET. J Hum Genet 2006; 51 : 665-670
23. Klinkert ER, teVelde ER, Weima S, et al. FSH receptor genotype is associated with pregnancy but not with ovarian response in IVF. Reprod Biomed Online 2006 ; 13 : 687-695
24. Laven JS, Mulders AG, Suryandari DA, etal. Follicle-stimulating hormone receptor polymorphisms in women with normogonadotropic anovulatory infertility. Fertil Steril 2003 ; 80 : 986-992
25. 25. Loutradis D, Patsoula E, Minas V, et al. FSH receptor gene polymorphisms have a role for different ovarian response to stimulation in patients entering IVF/ICSI-ET programs. I Assist Reprod Genet 2006 ; 23 : 177-184 (Pubitemid 43873809)
26. Ludwig A, Murawska M, Panek G, Timorek A, Kupryjanczyk J. Androgen, progesterone and FSH receptor polymorphisms and ovarian cancer risk and outcome. Endocr Relat Cancer 2009 (Epub ahead of print).
27. 27. Méduri G, Massin N, Guibourdenche J, et al. Serum antiMüllerian hormone expression in women with premature ovarian failure. Hum Reprod 2007 ; 22 : 117-123 (Pubitemid 44942674)
28. 28. Montanelli L, Delbaeren A, Di Carlo C, et al. A Mutation in the follicle-stimulating hormone receptor as a cause of familial spontaneous ovarian hyperstimulation syndrome. I Clin Endocrinol Metab 2004; 89: 1255-1258 (Pubitemid 38368422)
29. 29. Ohtani K, Sakamoto H, Kikuchi A, et al. Follicle-stimulating hormone promotes the growth of human epithelial ovarian cancer cells through the protein-kinase C-mediated system. Cancer Lett 2001 ; 166:207-213 (Pubitemid 32322667)
30. 30. Perez Mayorga M, Gromoll J, Behre HM, Gassner C, Nieschlag E, Simoni M. Ovarian response to follicle-stimulating hormone (FSH) stimulation depends on the FSH receptor genotype. J Clin Endocrinol Metab 2000 ; 85 : 3365-3369 (Pubitemid 30944552)
31. 31. Shanbhag S, Aucott L, Bhattacharya S, Hamilton MA, McTavish AR. Interventions for "poor responders" to controlled ovarian hyperstimulation (COH) in in vitro fertilisation (IVF). Cochrane Database Syst Rev 2007 : CD004379. (Pubitemid 351820481)
32. Simoni M, Tempfer CB, Destenaves B, Fauser BCJM. Functional genetic polymorphisms and female reproductive disorders: Part I: polycystic ovary syndrome and ovarian response. Hum Reprod Update 2008; 14:459-484
33. 33. Simoni M, Nieschlag E, Gromoll J. Isoforms and single nucleotide polymorphisms oft he FSH receptor gene: implications for human reproduction. Hum Reprod Update 2002 ; 8 : 413-421 (Pubitemid 35175203)
34. 34. Simoni M, Gromoll J, Höppner W, et al. Mutational analysis of the follicle-stimulating hormone (FSH) receptor in normal and infertile men: identification and characterization of two discrete FSH receptor isoforms. 1 Clin Endocrinol Metab 1999 ; 84 : 751-755 (Pubitemid 29075716)
35. 35. Simoni M, Gromoll J. The follicle-stimulating hormone receptor: biochemistry, molecular biology and pathophysiology. Endocr Rev 1997; 18: 739-773 (Pubitemid 28009566)
36. 36. Simoni M, Nieschlag E. FSH in therapy: Physiological basis, new preparations and clinical use. Reprod Med Rev 1995; 4: 163-177 (Pubitemid 26025938)
37. 37. Smits G, Olatunbosun O, Delbaere A, Pierson R, Vassart G, Costagliola S. Ovarian hyperstimulation syndrome due to a mutation in the follicle-stimulating hormone receptor. N Engl I Med 2003 ; 349 : 760-766 (Pubitemid 37010780)
38. 38. Sudo S, Kudo M, Wada S, Sato O, Hsueh AJ, Fujimoto S. Genetic and functional analyses of polymorphisms in the human FSH receptor gene. Mol Hum Reprod 2002 ; 8 : 893-899 (Pubitemid 35174921)
39. Sundblad V, Chiauzzi VA, Escobar ME, Dain L, Charreau EH. Screening of FSH receptor gene in Argentine women with premature ovarian failure (POF). Mol Cell Endocrinol 2004 ; 222 : 53-9.
40. te Velde ER, Pearson PL. The variability of female reproductive ageing. Hum Reprod Update 2002 ; 8 : 141-154
41. 41.Vasseur C, Rodien P, Beau I, et al. A chorionic gonadotropinsensitive mutation in the follicle-stimulating hormone receptor as a cause of familial gestational spontaneous ovarian hyperstimulation syndrome. N Engl / Med 2003 ; 349 : 753-759 (Pubitemid 37010779)
42. 42. Yang CQ, Chan KY, Ngan HY, et al. Single nucleotide polymorphisms of follicle-stimulating hormone receptor are associated with ovarian cancer susceptibility. Carcinogenesis 2006; 27: 1502-1506 (Pubitemid 43985424)
43. Zeleznik AJ. Protein-kinase B is obligatory for follicle stimulating hormone-induced granulosa cell differentiation. Endocrinology 2003; 144:3985-3994